New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs
|
By LabMedica International staff writers Posted on 27 Jul 2023 |

New research presented at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo has shown that self-collected tests are as effective as provider-collected tests in detecting prevalent sexually transmitted infections (STIs). These findings could pave the way for new, discreet testing options that expand access to STI screening.
The human papillomavirus (HPV) is a primary cause of cervical cancer in the U.S., creating the need for regular testing as part of prevention and screening measures. Testing traditionally occurs in clinical environments, but there's increasing interest in using self-collected samples for HPV and other STIs. Such self-administered tests could potentially benefit those who find it difficult to access healthcare providers due to their location, profession, or fear of stigma or discrimination. Nevertheless, additional research is needed to confirm the reliability of these self-collected tests.
Researchers from LetsGetChecked Laboratories (New York, NY, USA) and the Permanente Medical Group (Oakland, CA, USA) performed a comparative study on HPV tests using 144 pairs of self-collected vaginal swabs and healthcare provider-collected swabs from the cervix lining. Additionally, they exposed a small selection of self-collected samples to temperatures that simulate extreme seasonal fluctuations. To assess the variability in swabs from a single individual, likely due to differing virus quantities in each swab, the researchers evaluated five self-collected swabs from 15 participants.
Lastly, the team explored methods to enhance the collection process, like modifying the duration samples were left to dry and providing participants with an instructional video. The majority of self-collected samples delivered results consistent with those from provider-collected ones. Differences were attributed to smaller amounts of detectable virus in self-collected samples. Those samples exposed to extreme temperatures had less detectable virus than those not subjected to such conditions. However, changes in the drying time of samples did not affect virus detection. Sample validity saw an improvement of 8.5% after participants viewed an instructional video.
“We performed a detailed analysis of the variables related to self-collected vaginal swabs to calculate analytical acceptability metrics, and to identify limitations in testing that can be improved to aid in modern cervical cancer screening,” said primary author Michelle Qi.
In another study, researchers from the Los Angeles County Department of Public Health (Baldwin Park, CA, USA) and LetsGetChecked analyzed the performance of self-collected tests versus provider-collected tests for two common sexually transmitted infections (STIs): Chlamydia trachomatis and Neisseria gonorrhea. These infections frequently present without symptoms, making them challenging to detect. The Centers for Disease Control and Prevention suggest that self-collected samples, obtained from urine or swabs of the vagina, rectum, or throat, could serve as practical alternatives to provider-collected samples. At present, only urine and vaginal swabs can be self-collected within clinics. This research was initiated with the aim of broadening the inclusivity and accessibility of STI testing by examining more options for self-collection and home testing.
The researchers evaluated results from 164 pairs of rectal swabs collected at home and by providers, and 159 pairs of throat swabs. They also conducted tests on urine and vaginal swabs to determine the effects of temperature fluctuations, contamination from hands, and inaccurate filling of self-collected urine samples. When compared to provider-collected samples, the self-collected rectal swabs showed 95.5% positive agreement for C. trachomatis and a perfect 100% for N. gonorrhea. Meanwhile, self-collected throat swabs were nearly 100% consistent with provider-collected swabs for both infections. Notably, there were several swabs that tested positive for both pathogens when self-collected but tested negative when collected by providers. The presence of hand contaminants had a negligible impact on test outcomes, and the results remained largely unaltered by temperature fluctuations and incorrect filling of urine samples.
“Self-collected rectal and throat swabs could offer better sensitivity than those collected by physicians for detecting C. trachomatis and N. gonorrhea—without compromising the test’s analytical performance,” said Breland Hockman, Ph.D., one of the study’s authors. “Therefore, specimens of STIs collected at home offer a viable option for improving access to STI screening and could offer a non-stigmatizing approach to sexual health.”
Related Links:
LetsGetChecked Laboratories
Permanente Medical Group
LA County Public Health
Latest AACC 2023 News
- First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award
- Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023
- Laboratory Experts Show How They Are Leading the Way on Global Trends
- Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors
- Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023
- Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections
- AI Predicts Multiple Sclerosis Risk, Flags Potentially Contaminated Lab Results
- Scientific Session Explores Role of Technology in New Era of Specimen Transport
- Prevencio Presents AI-Driven Platform for Medical Diagnostic Test Development
- Scientific Session Explores Future Role of AI and ML in Clinical Laboratory
- SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs
- World's First Large Sample Volume, Open-Assay, Super-fast, Ultra-Sensitive, and Sample-To-Answer PCR Instrument
- Vital Biosciences Unveils Revolutionary POC Lab Testing Platform
- World's Smallest POC Device for Complete Blood Count in 30 Minutes Unveiled
- General Biologicals Unveils CTC Cancer Detection Products and Automated Molecular System
- Fapon Showcases Innovative Diagnostic and Biopharma Solutions
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








